Here, we investigated the effects of ASP7657, a highly potent and selective EP4 antagonist [23], on myeloid cells including DCs in vitro and in vivo, and tumor growth inhibition through activation of antitumor immunity. The gene discussed is PTGER4; the disease is neoplasm.